Event-Driven Stocks

ABVC BIOPHARMA, INC.

ABVCNasdaq

Healthcare · Pharmaceutical Preparations · NV · SEC filings ↗ · Compare ⊕

View price & chart on Yahoo Finance ↗
Signs● 2 good● 3 warning● 2 severedetails ↓

Financials

SEC XBRL · annual
 FY25FY24FY23FY22FY21FY20
Revenue$296,000$0$152,430$969,783$355,797$483,045
Operating income−$7.2M−$4.7M−$6.8M−$15.1M−$11.7M−$8.5M
Net income−$7.9M−$4.9M−$7.8M−$16.4M−$12.8M−$10.6M
Total assets$21.1M$7.5M$7.8M$9.6M$13.7M$11.6M
Total liabilities$7.8M$6.8M$6.5M$6.3M$4.8M$8.9M
Equity$11.1M$1.2M$1.6M$3.1M$8.8M$3.4M
EPS (diluted)$-0.39$-0.42$-1.80$-5.19$-0.51$-0.50
Shares out.15.8M10.6M33.1M30.3M24.4M19.5M

Reported figures from the company's SEC filings (XBRL). Blank where a line item isn't cleanly tagged — never estimated.

Key ratios

from filings · FY2025
Operating margin
−2416.0%
Net margin
−2671.8%
Return on equity
−71.2%
Return on assets
−37.5%
Return on capital (ROCE)
−48.0%
Liabilities / assets
36.9%
Debt / equity
0.70×
Book value / share
$0.70
Revenue growth (YoY)
—
Net income growth (YoY)
—

Computed from the company's own SEC figures — no market price, so these are facts, not a valuation. Book value per share is reported equity ÷ shares; it is not the stock price.

Financial health

forensic scores · FY2025
Altman Z″ (distress)
-13.82distress
Accruals / assets
−23.4%clean
Piotroski F-Score
5/8mixed

Altman Z″is a textbook bankruptcy-distress score from book values only (>2.6 safe · 1.1–2.6 grey · <1.1 distress). Accruals = (net income − operating cash flow) ÷ assets; persistently high accruals are an earnings-quality red flag. Beneish M-Scoreis an eight-ratio screen comparing this year with last (M > −1.78 = elevated manipulation-risk screen, not proof). Piotroski F-Scorecounts how many of nine fundamental-health checks pass (shown as passed / applicable; we use operating margin and total liabilities as documented proxies where the exact input isn't XBRL-tagged). Computed from SEC filings — descriptive factors, not advice or a forecast.

Quality score

EDS Score
46
/ 100
Profitability 0Growth n/aCatalyst 67Earnings quality 67Financial strength 50

Our own multi-factor score from free SEC data — profitability, growth, financial strength, earnings quality, and event/ownership catalysts. No market price and no licensed model: each axis is the share of source-backed checks it passes. Descriptive factors, not advice or a forecast.

Signs

● 2 severe● 3 warning● 2 good
  • Altman Z″ in the distress zone
  • Filed a late-filing notice (Form NT) — missed an SEC deadline
  • Operating losses (negative operating margin)
  • Reported a net loss
  • Negative operating cash flow
  • Conservative leverage (liabilities < 50% of assets)
  • Clean earnings (low accruals)

Derived from the company's own SEC figures (fundamentals, forensic scores, filing discipline) — descriptive factors, not advice or a forecast.

Risk flags

late SEC filings

A Form NT means the company notified the SEC it would file a periodic report late — often an accounting, audit or liquidity warning sign. Also search SEC enforcement actions for this company.

5%+ owners

SEC Schedule 13D / 13G · last 3 yrs

Holders who disclosed a 5%+ stake. 13D signals intent to influence or control; 13G is a passive holding. Latest filing per holder — open it for the exact stake.

Short interest

FINRA · bi-monthly
SettlementShares shortDays to coverΔ vs prior
May 15, 2026272,6793.5+5.8%
Apr 30, 2026257,8323.8-12.7%
Apr 15, 2026295,2741.3+11.3%
Mar 31, 2026265,2804.7+7.1%
Mar 13, 2026247,6683.9+0.4%

Shares sold short as reported to FINRA. Days-to-cover = short shares ÷ average daily volume — higher means more potential squeeze pressure.

Material events

SEC Form 8-K · most recent

Events the company reported on Form 8-K, labelled by the SEC item code it filed under — its own classification, not our interpretation.

Recent SEC filings

All filings ↗

Event-driven situations (3)